Adonia E. Papathanassiu

Statistics

Publications

Citations

675

H-Index

Active since

1999

Affiliations

Aegerion Pharmaceuticals (United States)(Current)

CASI Pharmaceuticals (United States)

Ergon Energy (Australia)

Imperial College London

Adonia E. Papathanassiu is an author at Aegerion Pharmaceuticals (United States) specializing in life sciences, biochemistry, and cancer pharmacology.

Publications per year

1999–2020

Publications

BCAT1 controls metabolic reprogramming in activated human macrophages and is associated with inflammatory diseases

Adonia E. Papathanassiu, Jeong‐Hun Ko, Martha Imprialou et al. · Nature Communications · 2017 · 241 citations · Full text

Life Sciences, Biochemistry, Immunology +17

Tissue factor/factor VIIa inhibitors block angiogenesis and tumor growth through a nonhemostatic mechanism.

Todd Hembrough, Glenn M. Swartz, Adonia E. Papathanassiu et al. · PubMed · 2003 · 197 citations

Medicine, Cancer Biology, Oncology +14

Tissue Factor Pathway Inhibitor Inhibits Endothelial Cell Proliferation via Association with the Very Low Density Lipoprotein Receptor

Todd Hembrough, José F. Ruiz, Adonia E. Papathanassiu et al. · Journal of Biological Chemistry · 2001 · 75 citations · Full text

Life Sciences, Molecular Biology, Pharmacology +8

BCAT1 affects mitochondrial metabolism independently of leucine transamination in activated human macrophages

Jeong‐Hun Ko, Antoni Olona, Adonia E. Papathanassiu et al. · Journal of Cell Science · 2020 · 45 citations · Full text

Life Sciences, Biochemistry, Cellular Metabolism +14

cAMP and cGMP in Human Parotid Saliva: Relationships to Taste and Smell Dysfunction, Gender, and Age

Robert I. Henkin, Irina Velicu, Adonia E. Papathanassiu · The American Journal of the Medical Sciences · 2007 · 36 citations

Dentistry, Endocrinology, Oral Biology +11

1–5 of 8